Silencing menin in AR-positive prostate cancer cell lines also reduces the expression of TMPRSS2 [307], an androgen-responsive transmembrane serine protease that promotes prostate cancer growth and metastasis [314,315,316]. The gene discussed is MEN1; the disease is prostate carcinoma.